Matches in Wikidata for { <http://www.wikidata.org/entity/Q92663050> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q92663050 description "article scientifique publié en 2019" @default.
- Q92663050 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92663050 description "scientific article published on 01 June 2019" @default.
- Q92663050 description "wetenschappelijk artikel" @default.
- Q92663050 description "наукова стаття, опублікована 1 червня 2019" @default.
- Q92663050 name "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 name "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 type Item @default.
- Q92663050 label "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 label "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 prefLabel "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 prefLabel "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 P1433 Q92663050-1C0101D0-ABE3-4307-A5AD-195FD6D4391E @default.
- Q92663050 P1476 Q92663050-408CD5A6-4203-4437-83F3-C42F3E937890 @default.
- Q92663050 P2093 Q92663050-1514F1AF-1D78-46EB-9F6F-FECFFD13EB5A @default.
- Q92663050 P2093 Q92663050-1B6BD4DE-264B-4677-B960-83B753117256 @default.
- Q92663050 P2093 Q92663050-29B2706E-1A86-4F21-A4CE-4F017EACC4E3 @default.
- Q92663050 P2093 Q92663050-D73E4188-713B-40DF-865F-972754D928F8 @default.
- Q92663050 P304 Q92663050-3B65C496-7BD6-45EC-9521-E4091AEB72E6 @default.
- Q92663050 P31 Q92663050-2B2667E4-BB07-4DA7-A89D-684BFC647660 @default.
- Q92663050 P31 Q92663050-607CE67B-2700-4BF8-9746-BCEA521E3766 @default.
- Q92663050 P356 Q92663050-D2BF86E5-733C-4EEC-9AD3-BA25A6337610 @default.
- Q92663050 P433 Q92663050-ADD513D8-2C6D-46C2-8841-B85D223EBB52 @default.
- Q92663050 P478 Q92663050-0E765E56-6711-47E3-ABF6-3F52E08602B9 @default.
- Q92663050 P50 Q92663050-025E91AD-ECE8-40C2-850E-3E73DE176914 @default.
- Q92663050 P50 Q92663050-965AB852-3669-413F-9239-64CA4F591755 @default.
- Q92663050 P50 Q92663050-AC5C0092-C584-4CEE-8A64-A3582A94996B @default.
- Q92663050 P50 Q92663050-D4DBEFFC-D485-476D-96ED-FBDBD07023BB @default.
- Q92663050 P50 Q92663050-DFC81EFD-BFC6-4D72-9ED1-E71C3B6A54D9 @default.
- Q92663050 P577 Q92663050-572799BA-5C72-4986-8F11-1CAA7CA04359 @default.
- Q92663050 P698 Q92663050-69C596D1-43D2-4BA8-ACDC-CF91C0A06A54 @default.
- Q92663050 P921 Q92663050-2B854CD7-7832-43B8-AF7A-EAACCB0B9C8D @default.
- Q92663050 P921 Q92663050-60F5ABCB-92B8-48EC-A6FD-2C24ED9CAAC6 @default.
- Q92663050 P921 Q92663050-7C38978A-6261-416E-9719-6A1D6FFD2FE1 @default.
- Q92663050 P932 Q92663050-D2C4BF82-D53A-4136-9585-DE3DCF114D0B @default.
- Q92663050 P356 S00262-019-02328-6 @default.
- Q92663050 P698 30919028 @default.
- Q92663050 P1433 Q5031409 @default.
- Q92663050 P1476 "Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial" @default.
- Q92663050 P2093 "Arnold Baars" @default.
- Q92663050 P2093 "Jorien Harting" @default.
- Q92663050 P2093 "Rik J Scheper" @default.
- Q92663050 P2093 "S Marieke van Ham" @default.
- Q92663050 P304 "1037" @default.
- Q92663050 P31 Q13442814 @default.
- Q92663050 P31 Q1348305 @default.
- Q92663050 P356 "10.1007/S00262-019-02328-6" @default.
- Q92663050 P433 "6" @default.
- Q92663050 P478 "68" @default.
- Q92663050 P50 Q55163202 @default.
- Q92663050 P50 Q86096547 @default.
- Q92663050 P50 Q90913412 @default.
- Q92663050 P50 Q92247917 @default.
- Q92663050 P50 Q92247919 @default.
- Q92663050 P577 "2019-06-01T00:00:00Z" @default.
- Q92663050 P698 "30919028" @default.
- Q92663050 P921 Q1164529 @default.
- Q92663050 P921 Q19000948 @default.
- Q92663050 P921 Q42824440 @default.
- Q92663050 P932 "6828222" @default.